Oncogenic IL7R is downregulated by histone deacetylase inhibitor in esophageal squamous cell carcinoma via modulation of acetylated FOXO1

International Journal of Oncology
Myoung Jun KimJueng Soo You

Abstract

The interleukin-7 receptor (IL7R) is generally expressed in immune cells and is critical in survival, development and homeostasis in the immune system. Advanced genome-wide cancer studies have reported that IL7R is genetically amplified in human esophageal squamous cell carcinoma (ESCC), however, the exact role of IL7R in ESCC has not been investigated. In the present study, it was found that IL7R was overexpressed in ESCC cohorts and the loss of IL7R induced anti-oncogenic effects in ESCC cell lines. A small panel of epigenetic drugs were screened for their ability to downregulate the expression of IL7R. Unexpectedly, apicidin, a histone deacetylase (HDAC) inhibitor, effectively downregulated the expression of IL7R in a dose-dependent manner at an early time-point, as determined by quantitative polymerase chain reaction and IL7R immunostaining, and did not require de novo protein synthesis. Of note, apicidin induced the acetylation of Forkhead box-containing protein, O subfamily 1, which acts as a repressor at the IL7R promoter, accompanied with depleted active histone modifications based on chromatin immunoprecipitation assay. Taken together, these results demonstrated that targeting oncogenic IL7R in ESCC by HDAC inhibitors ...Continue Reading

References

Apr 1, 1995·The Journal of Experimental Medicine·U von Freeden-JeffryR Murray
Nov 1, 1994·The Journal of Experimental Medicine·J J PeschonB L Davison
Sep 6, 2000·Proceedings of the National Academy of Sciences of the United States of America·N NasrinM C Alexander-Bridges
Sep 20, 2001·Current Medicinal Chemistry·M Jung
Aug 15, 2003·Journal of Cell Science·Claude Prigent, Stefan Dimitrov
Mar 10, 2004·The Biochemical Journal·Lars P Van Der HeideMarten P Smidt
Apr 7, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Christine A GoetzMichael A Farrar
Nov 13, 2004·The EMBO Journal·Marieke A G EssersBoudewijn M T Burgering
Mar 16, 2005·Proceedings of the National Academy of Sciences of the United States of America·Seung Wook OhHeidi A Tissenbaum
Apr 30, 2005·Trends in Endocrinology and Metabolism : TEM·Andreas BarthelTerry G Unterman
Jul 6, 2005·Cytokine & Growth Factor Reviews·Qiong JiangScott K Durum
Aug 4, 2005·Proceedings of the National Academy of Sciences of the United States of America·Hitomi MatsuzakiAkiyoshi Fukamizu
Sep 13, 2005·Cell Metabolism·Yukari Ido KitamuraDomenico Accili
Jan 7, 2006·Nature Reviews. Cancer·Saverio Minucci, Pier Giuseppe Pelicci
Apr 9, 2008·Oncogene·D R Calnan, A Brunet
Jun 1, 2007·Molecular Oncology·Santiago Ropero, Manel Esteller
Nov 26, 2010·Frontiers of Medicine in China·Xiao-Mei Zhang, Ming-Zhou Guo
Mar 15, 2011·Biochimica Et Biophysica Acta·Hiroaki DaitokuAkiyoshi Fukamizu
Feb 5, 2013·Lancet·Arjun PennathurJames D Luketich
Apr 2, 2013·Cell·Levi A Garraway, Eric S Lander
Apr 2, 2014·Nature Genetics·De-Chen LinH Phillip Koeffler
Jul 30, 2014·Archives of Pharmacal Research·Jueng Soo You, Jeong Hwan Han
Dec 30, 2014·The New England Journal of Medicine·Anil K Rustgi, Hashem B El-Serag
Sep 8, 2016·Cold Spring Harbor Perspectives in Medicine·Yixuan Li, Edward Seto
Sep 16, 2016·Nature Reviews. Genetics·Peter A JonesStephen Baylin

❮ Previous
Next ❯

Citations

Jun 13, 2019·Medicina·Iwona Bednarz-MisaMałgorzata Krzystek-Korpacka
Aug 28, 2020·Frontiers in Genetics·Abel SousaPedro G Ferreira

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.